Skip to main content
. Author manuscript; available in PMC: 2010 Apr 14.
Published in final edited form as: Cancer Prev Res (Phila). 2008 Sep;1(4):250–254. doi: 10.1158/1940-6207.CAPR-08-0060

Table 3.

Final models and results of 3-fold cross-validation analyses

Baseline model Baseline model + DRC Baseline model + bleomycin Baseline model + DRC + bleomycin
Former smokers
 Overall AUC 0.67 (0.63–0.71) 0.69 (0.65–0.73) 0.68 (0.64–0.72) 0.70 (0.66–0.74)
 Cross-validation mean AUC (95% CI) 0.68 (0.62–0.75)
P, goodness of fit 0.610
Current smokers
 Overall AUC 0.68 (0.64–0.72) 0.69 (0.64–0.73) 0.72 (0.68–0.77) 0.73 (0.69–0.77)
 Cross-validation mean AUC (95% CI) 0.70 (0.63–0.77)
P, goodness of fit 0.433